Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tetrahydrofuran | HCID 8028 | — |
| Reactant | 4-(4-Bromophenyl)-4-hydroxypiperidine | HCID 93911 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | 2(3-Chloropropyl)naphtho[1,8-cd]isothiazole 1,1-dioxide | HCID 14580026 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 86744822 | HCID 86744822 | — |
Reaction Steps
The experiment is carried out as in Exampe 1, starting with 2-(3-chloropropyl)naphtho[1,8-cd]isothiazole 1,1-dioxide (2.8 g), 4-hydroxy-4-(4-bromophenyl)piperidine (2.4 g) and sodium bicarbonate (0.94 g) in a mixture of dimethylformamide (80 cc) and tetrahydrofuran (50 cc). The mixture is heated for 5 hours to a temperature of about 100° C. then cooled to a temperature of about 20° C. Stirring is maintained for 15 hours at this temperature. After purification by flash-chromatography on a silica column, under a current of argon (0.5-1.5 bar) with a mixture of dichloromethane and methanol (95-5 vol) as eluant, and recrystallization from boiling ethyl acetate (50 cc), 2-(3-[4-(4-bromophenyl)-4-hydroxypiperidino]propylnaphtho[1,8-cd]isothiazole 1,1-dioxide (1.5 g) is obtained in the form of hydrochloride, of m.p. 110 C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05021420 |
|---|
| Source dataset | uspto-grants-1991_06 |
|---|
| ORD ID | ord-83eb0bbf210f4e4c96d57564004bd93d |
|---|
| Source note | uspto-grants-1991_06 |
|---|